Chlamydia trachomatis infection induces an inflammatory response that is crucial in resolving acute infection but may also play a key role in the pathogenesis of C trachomatis associated infertility. The immune response is linked to cytokine secretion pattern which is influenced by the host genetic background. To study a relationship between interleukin-10 (IL-10) promoter À1082 polymorphism and cell-mediated immune response during C trachomatis infection in vitro, lymphocyte proliferation and cytokine (IL-10, IFN-g, TNF-a, IL-2, IL-4 and IL-5) secretion were analysed in subjects with different IL-10 genotypes. Enhanced IL-10 secretion and reduced antigen-specific lymphocyte proliferative and IFN-g responses were found in subjects with IL-10 À1082 GG genotype when compared to those with À1082 AA genotype. CD14 þ monocytes were main source of IL-10 indicating that these cells are important regulators of the antigen-specific cell-mediated responses during active C trachomatis infection. We conclude that impaired cell-mediated response to C trachomatis is associated with IL-10 genotype in subjects with high IL-10 producing capacity. A comparison of immune markers between subjects with a history of noncomplicated and complicated infection is needed to further understand the confounding factors associated with the development of C trachomatis associated sequelae.
Introduction
Chlamydia trachomatis is an obligate intracellular bacterium and a major cause of sexually transmitted bacterial infections worldwide. Chlamydial infections are typically asymptomatic and reinfections are common. Spreading of infection to the upper reproductive tract eventually leads to pelvic inflammatory disease, fallopian tube scarring and tubal factor infertility (TFI). 1, 2 As an intracellular pathogen C trachomatis infection induces antigen-specific cell-mediated immune (CMI) response of T-helper cell type 1 (Th1). 3 Th1 cytokines interleukin-12 (IL-12), TNF-a and most notably IFN-g are crucial in resolving primary chlamydial infection. 4 Antigen-specific IFN-g secreting T cells correlate with protection. 5 Low number of mucosal CD4 þ T cells or reduced IFN-g secretion is associated with C trachomatisinduced tissue damage, 6 and increased incidence of C trachomatis infection. 7 Some individuals are more susceptible to C trachomatis infection and associated sequelae than others. Endogenous IL-10, an efficient suppressor of Th1 responses, impairs the clearance of C trachomatis in mice, 8 and predisposes infected animals to reinfection. 9 Furthermore, neutralization or lack of IL-10 8, 10 improves protective immunity in mice. Our previous observation that CHSP60 induces higher IL-10 secretion by lymphocytes from women with TFI 11 is consistent with an association between CHSP60-induced IL-10 secretion and increased risk of C trachomatis infection. 7 On the other hand, a link between TFI and certain HLA class II alleles 12, 13 or IL-10 -1082 AA genotype 14 suggests that genetic factors may be involved in C trachomatis associated TFI.
We wanted to analyse further the relationship between CMI response to C trachomatis, IL-10 production, and IL-10 promoter À1082 single point polymorphism (SNP). We studied cytokine secretion of subjects with different IL-10 genotypes by infecting peripheral blood mononuclear cells (PBMC) in vitro with C trachomatis. We found a reduction of Chlamydia-specific CMI and enhanced IL-10 secretion in subjects with IL-10 À1082 GG genotype compared to those with À1082 AA genotype. Most IL-10 secretion originated from CD14 þ monocytes suggesting that these cells are important regulators of antigenspecific CMI responses during active C trachomatis infection.
Results
Interleukin-10 promoter gene polymorphism and C trachomatis infection Our study population consisted of 175 voluntary blood donors (median age 41 years, range 18-59) and 75 women (33; 23-40) attending in vitro fertilization treatment due to TFI. Serum samples were available of 49 controls and 74 cases. Serum IgG antibodies to C trachomatis were found less frequently in the controls than in the TFI cases (10 vs 45%; Po0.001). A SNP analysis of IL-10 À1082 showed that the frequency of À1082A allele was 0.48 in controls and 0.59 in TFI cases and that of IL-10 À1082G allele was 0.52 and 0.41, respectively. No difference was found in C trachomatis seroprevalence rates or antibody levels between different IL10 À1082 genotypes (Figure 1 ) in the TFI cases (AA 44.4%, AG 48.5 and GG 35.7%) and controls (AA 0, AG 16.7 and GG 0%) suggesting that antibody response is not related to IL-10 genotype.
C trachomatis-specific CMI responses C trachomatis-induced CMI responses were first studied by a conventional lymphocyte proliferation (LP) assay. The LP responses were similar to C trachomatis serotype E (median response 7.9; 25-75% percentiles 1.5-32.9) and serotype F (7.9; 1.7-34.1). Positive LP responses (SI45) to either one of C trachomatis serotypes were found in 56 and 63% of the controls and 87 and 91% of the TFI cases, respectively (Po0.001). We also studied the LP responses to C pneumoniae antigen (median response SI 9.6; 2.5-27.6) and found positive response in 76% of the controls and in 73% of the TFI cases.
When evaluating the LP responses by IL-10 polymorphism, the responses to all antigens used were strongest with the AA genotype and weakest with the GG genotype, both in the controls and in the TFI cases. The TFI cases and controls showed similar responses ( Figure 1b) .
Cytokine concentration in cell culture supernatants In order to evaluate the role of IL-10 and IL10 À1082 polymorphism on IL-10 secretion and indirectly on a balance of type 1 and type 2 cytokines, we studied the presence at type 1 (IL-2, IFN-g and TNF-a) and type 2 (IL-4, IL-5 and IL-10) cytokines in culture supernatants of PBMCs infected by C trachomatis in vitro. The experiments were performed in 33 individuals who represented different IL-10 À1082 genotypes (11 AA, 17 AG and 5 GG) and were selected based on to their positive LP responses to chlamydial EB.
C trachomatis (0.002 inclusion forming units (IFU))-induced IL-4 and IL-5 responses did not significantly differ from the background levels (o13.2 pg/ml for IL-5 and o5.5 pg/ml for IL-4). C trachomatis-induced IL-2 production differed clearly from the background level, although the concentrations were relatively low (3.1-29.0 pg/ml for C trachomatis and 0.5-20.3 pg/ml for background, Po0.001). Interleukin-2 concentrations tended to be higher both in the TFI cases and controls with IL-10 AA genotype than in those with GG genotype (Figure 2 ).
C trachomatis-induced IL-10 secretion was stronger among subjects with GG genotype (median IL-10 production 12702 pg/10 6 monocytes) than in those with AG (3782 pg/10 6 monocytes) or AA genotype (4437 ptg/ 10 6 monocytes; Po0.001) and the variation was largest in the AG genotype. Interleukin-10-induced Th1 downregulation was reflected to production of proinflammatory cytokines and C trachomatis-induced IFN-g and TNF-a secretions were clearly stronger in subjects with AA (median IFN-g production 356 pg/10 6 lymphocytes and TNF-a 1740 pg/10 6 monocytes) genotype compared to those with AG (86 pg/10 6 lymphocytes and 1356 pg/10 6 monocytes) or GG genotype (0 pg/10 6 lymphocytes and 0 pg/10 6 monocytes, respectively; Po0.05) ( Figure 2 ).
Intracellular cytokine production
In order to study the role of monocytes and CD4 þ and CD8 þ T cells as regulators of the immune response we analysed intracellular IL-10 and IFN-g production in C trachomatis infected cells using immunofluorescense Chlamydia immunity and IL-10 H Öhman et al technique by FACS. Histogram analysis of CD4 þ / CD3 þ and CD8 þ /CD3 þ T cells revealed that the median percentage of IFN-g secreting cells was higher among CD4 þ (median 12.6%) than among CD8 þ (median 4.8%) T cells ( Figure 3 ). However, a statistically significant increase compared to uninfected cells was found in both T-cell subgroups. A significant increase of IL-10 secreting CD14 þ monocytes was detected in C trachomatis-infected cells compared to uninfected cells (Table 1 and Figure 4 ), but only a marginal increase in IL-10 secreting capacity of CD3 þ cells. The enhanced secretion of intracellular cytokines was more prominent in cells infected with higher infectious dose revealing that the technique is less sensitive than ELISA and not suitable for quantitative analysis of cytokine responses ( Table 1) .
Influence of interleukin-10 and IFN-g on C trachomatis-specific cell response Influence of the IL-10 and IFN-g cytokines on C trachomatis-induced CMI responses was further studied by coculturing PBMC in the presence of recombinant IL-10 and IFN-g. As expected, adding exogenous IFN-g supported and adding exogenous IL-10 inhibited the LP responses ( Figure 5 ).
When IL-10 was blocked by adding anti-IL-10 antibody LP responses increased in all genotype groups. The increase was greatest in GG group but due to low number of subjects, did not reach statistical significance.
However, the responses remained lower than in the AA group.
Discussion
Individual variation in IL-10 gene polymorphism or functional IL-10 cytokine levels has been linked to various autoimmune, immunosuppressive or inflammatory conditions 15 including C trachomatis infection. [11] [12] 14, 16, 17 Quantitative association between IL-10 À1082 SNP polymorphism and IL-10 production has been previously demonstrated by unspecific stimulation of lymphocytes with LPS or ConA, 18 but the role of IL-10 counteracting antigen-specific CMI responses has remained unclear. In this study, we demonstrated that IL-10 À1082 SNP is linked to IL-10 secretion as well as to interaction between in vitro infected monocytes and antigen-specific T-cell responses. C trachomatis-induced immune responses could be divided into those with low IL-10 secretion and clearly positive LP responses, and into those with high IL-10 secretion and diminished LP responses, IFN-g and TNF-a responses. The central inhibiting role of IL-10 was confirmed by enhanced CMI response following blocking of IL-10 with neutralizing anti-IL-10 antibody. The increase was greatest among high IL-10 producers, with IL-10 À1082 GG genotype suggesting that CMI responses to C trachomatis may be activated in favourable conditions even in these subjects. Excessive IFN-g was not able to prevent inhibition of the LP responses which speaks for a dominant role of IL-10. The influence of IL-10 genotype on LP responses was similar regardless of the antigen or the study group. Thus, the genotype may not be related to clinical disease, but rather reflects the type of immune response in the presence of an intracellular microorganism. Chlamydia immunity and IL-10 H Öhman et al
We also studied the relative contributions of Chlamydia-specific T cells as a source of IL-10 and the counteracting IFN-g. In accordance to animal data 4,5 both the CD4 þ and CD8 þ cells seem to secrete IFN-g. The number of IL-10 secreting CD3 þ T cells increased marginally following C trachomatis infection, which is in accordance with our previous study in which IL-10 secreting C trachomatis-specific T cells were occasionally detected in inflamed salpingeal tissue. 19 However, IL-10 secretion predominantly originated from CD14 þ monocytes suggesting that the role of IL-10 secreting T cells in the course of TFI pathogenesis 19 is less important than that of CD14 þ monocytes. Their influence is especially strong among subjects with IL-10 À1082 GG genotype in whom even an immunocompetent activation of Th1 response may be switched off during an active phase of microbial invasion.
According to our results, subjects with IL-10 À1082 AA genotype and a clear linkage with low IL-10 secretion capacity, had prominent CMI responses including LP and secretion of IFN-g, TNF-a and IL-2. Considering the importance of IFN-g for host defence against C trachomatis infection in animals 4 and humans, 7, 20 it is tempting to speculate that subjects with AA genotype are better equipped against intracellular infections than those with GG genotype. However, this contradicts our earlier observation of a link between IL-10 À1082 AA genotype and chlamydial TFI, 14 reminding of a paradoxical role of IFN-g. Although IFN-g inhibits chlamydial growth in vitro, 21 insufficient IFN-g levels may predispose to persistent chlamydial infection. This hypothesis is mainly based on in vitro experiments, where low amount of IFN-g leads to the development of an infection with noninfectious but viable Chlamydiae resembling those seen in chronic infections. 22 This is in line with a positive correlation between CHSP60-induced IFN-g production and C trachomatis infection incidents. 7 We were unable to evaluate whether the IFN-g levels produced by subjects with IL-10 À1082 AA genotype were sufficient for host defence during acute C trachomatis infection at otherwise favourable conditions. It is possible that the link between the AA genotype and chlamydial TFI depends on other confounding factors, in addition to host genome.
Several confounding factors can complicate the immune mechanisms during an intracellular bacterial infection. 23 Prematurely downregulated Th1 activity by IL-10 and other anti-inflammatory factors can lead to persistent C trachomatis infection where the presence of infectious organisms maintain continuous inflammation leading to tissue damage. 24 Especially genital strains of C trachomatis have adapted to host IFN-g-mediated defence mechanisms by developing genetically regulated means to replace IFN-g-induced tryptophane depletion. 25 Moreover, concomitant infection with another Th2 activating microorganism, 26 preexistence of microenvironmental cytokines, 27 or hormonal status of the host 28 may compromise Th1 activation following C trachomatis infection.
We conclude that comparison of immune markers between subjects with history of noncomplicated or complicated infection is needed to further understand the confounding factors associated with the development of pathological sequelae of C trachomatis infection.
Materials and methods

Study population
The study population consisted of 250 women (range of age 18-59 years) of whom 75 attended in vitro fertilization treatment due to laparoscopically verified TFI and 175 women were voluntary blood donor controls whose buffy coat specimens were provided by the Finnish Red Cross Blood Transfusion Service (Oulu, Finland). Following informed consent, peripheral blood samples were taken for immunological and DNA studies, and transferred to the laboratory at room temperature. Plasma was separated and stored at À201C for the antibody analysis. The study protocol was approved by the Ethics Committee of the Department of Obstetrics and Gynaecology, University Hospital, Helsinki.
Detection of interleukin-10 promoter polymorphism DNA was extracted from polymorphonuclear leukocytes by a salting out method and IL-10 promoter gene polymorphism of a single nucleotide at position À1082 (A/G) was determined by polymerase chain reaction (PCR) technique. Alleles were amplified in separate tubes with sequence-specific oligonucleotide primers published by Karhukorpi and Karttunen. 29 Polymerase chain reaction was performed in a total volume of 10 ml using B100 ng template DNA, 1 Â PCR buffer (Promega, Madison, USA), 1.5 mmol/l MgCl 2 (Promega), 20 mmol/l of each nucleotide (Promega), 0.5 U Taq polymerase (Promega) and 0.25 mmol/l of each primer. After initial denaturation at 951C for 5 min, 30 cycles, consisting of denaturation for 30 s at 951C and annealing for 30 s at 641C were run. Final elongation was run for 6 min at 721C. The PCR products were separated on a 2% agarose gel and visualized under UV light illumination with ethidium bromide stain. The results were documented photographically (Kodak DC 120 Zoom).
Antibody analysis
Serum IgG antibodies specific to C trachomatis were analysed using peptide-based ELISA (Medac Diagnostika, Hamburg, Germany) accoding to the manufacturer's instructions. Results are measured as absorbance at 450 nm, and OD40.4 is considered positive.
Antigens used for lymphocyte cultures
Lymphocyte stimulating antigens included EB antigen of C trachomatis E and F serovars representing most prevalent inducers of C trachomatis infection among the Finnish population 30 and C pneumonia (K7) EB antigen. Lymphocyte proliferation analysis were preliminarily performed using formalin-inactivated chlamydial EB antigen in a total protein concentration of 0.6 mg/ml.
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In vitro infection of PBMC was performed with infectious C trachomatis EB. Optimum number of chlamydial EB were determined for the cytokine analysis in preliminary experiments with diluted EB stocks ranging from 2.0 to 0.002 IFU/ml.
Pokeweed mitogen (12.5 mg/ml PWM, Gibco, Paisley, UK) served as a control mitogen for lymphocyte analysis. Measurement of cytokine production from cell culture supernatants Interleukin-2, IL-4, IL-5, IL-10, IFN-g and TNF-a cytokines were measured from in vitro-infected or uninfected culture supernatants (0.002 IFU/cell of pooled E and F serovars) of 10 5 PBMC/well using Human Th1/Th2 Cytokine Cytometric Bead Array kit (CBA) (BD Biosciences, San Diego, CA, USA) according to the manufacturer's instructions. The PBMC supernatant was collected after 2 days and stored at À801C until analysis. The samples were measured on flow cytometer (FACSCalibur, BD Biosciences) and data were analysed with BD CellQuest and BD CBA software packages. Pokeweed mitogen-induced cytokine responses were clearly positive in all individuals (410 Â background) level indicating that the method was sensitive to the cytokines tested.
Lymphocyte proliferation
Proportions of CD14 þ monocytes and CD3 þ T cells among the cultured PBMC were analysed using immunofluorescense technique. Peripheral blood mononuclear cells were stained with PerCP-conjugated antihuman CD3 and APC-conjugated anti-human CD14 and analysed with FACSCalibur cytometer (BD Biosciences).
Resulted cytokine concentrations are presented as cytokine concentration (pg/10 6 cells) after subtraction of the background level (cytokine production of unstimulated cells). Interleukin-10 and TNF-a concentrations are proportioned to the number of CD14 þ monocytes, and IFN-g and IL-2 concentrations to the number of CD3 þ lymphocytes within the corresponding culture.
Intracellular cytokine analysis
Intracellular cytokine analyses were performed on in vitro-infected or uninfected PBMC cultures using immunofluorescense technique with BD Cytofix/Cytoperm kit (BD Biosciences). Brefeldin A containing BD GolgiPlug solution was added to the PBMC cultures after 30 h of incubation to prevent the secretion of cytokines. After 10 h, later the cells were stained for surface and intracellular antigens. The cell surface antigens were stained with PerCPconjugated anti-CD3, PE-conjugated anti-CD4 and FITCconjugated anti-CD8 in the case of IFN-g analysis and with PerCP anti-CD3 and APC anti-CD14 in the case of IL-10 analysis. After fixation and permeabilization the intracellular cytokines were stained with FITC conjugated anti-IFN-g or PE-conjugated anti-IL-10 monoclonal antibody. All antibodies and appropriate isotype control antibodies were purchased form BD Biosciences. Cells were measured on FACSCalibur cytometer. Cell populations were gated according to their surface antigens and cytokine production was determined from different subpopulations as percentage of positively stained cells for IFN-g and IL-10.
Statistical analyses
The statistical analyses were performed with SPSS for Windows 11.5. software (SPSS Inc., Chicago, IL, USA). w
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Test was used to compare categorical variables between the study groups and continuous variables were compared by nonparametric Mann-Whitney U-test or Wilcoxon signed-rank test.
Abbreviations LP, lymphocyte proliferation; PBMC, peripheral blood mononuclear cells; TFI, tubal factor infertility; CMI, cellmediated immune.
